Manufacture of pharmaceutical preparations
VISTIN PHARMA AS
Revenue 2024
NOK 429.5m
Operating profit
NOK 91.3m
Equity
NOK 174.3m
Incorporated
2014
Employees
78
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 429.5m | |
| Total operating costs | 338.2m | |
| Operating profit (EBIT) | 91.3m | |
| Net financial items | −6.4m | |
| Profit for the year | 66.3m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 376.0m | |
| of which current assets | 134.2m | |
| Equity | 174.3m | |
| Total liabilities | 201.7m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.